At 6 hpi, PR1 promoter activity appeared to be enhanced in NLR-activating inoculations compared to Pst DC3000 hrcC-, suggesting that NLR signaling increased defense around the infection site (SI Appendix, Fig. S5A). Here, TMEM37 is linked to infection.